Related Experiment Video
Updated: May 5, 2026

Chinese Herbal Retention Enema for the Treatment of Ulcerative Colitis
Published on: May 16, 2025
Latent profiles of self-management behavior and associated factors among Chinese patients with ulcerative colitis
Man Yang1, Huiying An1, Lei Lei1
1Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Background:
Ulcerative colitis (UC) poses a growing clinical and socioeconomic burden in China. Effective self-management is critical for long-term disease control, yet significant heterogeneity exists in self-management behavior (SMB) among patients. This study aimed to identify latent profiles of SMB and examine associated factors among patients with UC.
Methods:
In this cross-sectional study, 415 UC patients completed validated measures including the IBD Self-management Scale (36 items, 7 domains), the Connor-Davidson Resilience Scale-10 (CD-RISC-10), Patient Health Questionnaire-9 (PHQ-9), Family Communication subscale of the Family Assessment Device, and Social Support Rating Scale (SSRS). Latent profile analysis (LPA) was used to identify distinct SMB patterns. Multinomial logistic regression (R3STEP procedure) examined factors associated with profile membership, with the largest class (Low-Monitoring) as the reference.
Results:
Three latent profiles were identified: Low-Monitoring (53.97%), characterized by poor symptom surveillance and exercise management; Emotion-Adaptive (37.11%), with strong emotion regulation but limited resource utilization; and High-Engagement (8.92%), demonstrating balanced and proactive self-management across domains. Compared with the Low-Monitoring group, patients in the Emotion-Adaptive and High-Engagement profiles had significantly higher social support (OR = 1.054 and 1.102, respectively; both p < 0.01) and lower depressive symptoms (OR = 0.856 and 0.539, respectively; both p < 0.01). High-Engagement members also showed higher psychological resilience (OR = 1.112, p = 0.009) and better family communication (OR = 1.466, 95% CI: 0.985 2.181, p = 0.049), although the latter association was of borderline statistical significance. Rural residence, middle income, and being in clinical remission were associated with lower odds of belonging to more engaged profiles.
Conclusion:
Despite the single-center design and a predominantly hospitalized cohort limiting generalizability to outpatient or community populations, this study characterizes the heterogeneity of self-management behavior (SMB) among Chinese patients with UC through latent profile analysis, identifying a behavioral typology that provides a descriptive framework for understanding patient-reported outcomes.
Related Concept Videos
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease II: Ulcerative Colitis
Inflammatory Bowel Disease IV: Clinical Manifestations
Irritable Bowel Syndrome III: Medical and Nursing Management
